Current practice perspectives on the management of thrombosis in children with renal insufficiency: The results of a survey of pediatric hematologists in North America

Pediatric Blood and Cancer

Volumn 51, Issue 5, 2008, Pages 657-661

  Sharathkumar, Anjali Alatkar ^a  

^a INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

Author keywords

Children; Management; Renal insufficiency; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; ARGATROBAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; COUMARIN; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; HIRUDIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY;

ANTICOAGULATION; ARTICLE; CLINICAL PRACTICE; DRUG ACCUMULATION; DRUG SAFETY; HEALTH SURVEY; HEMATOLOGY; HUMAN; KIDNEY FAILURE; NORTH AMERICA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST; SUPERIOR CAVA VEIN SYNDROME; THROMBOPHILIA; THROMBOSIS; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; CHILD; HEMATOLOGY; HUMANS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RENAL INSUFFICIENCY; VENOUS THROMBOSIS;

EID: 52249100540     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21653     Document Type: Article

References (20)

1. Zaffanello M, Franchini M. Thromboembolism in childhood nephrotic syndrome: A rare but serious complication. Hematology 2007;12:69-73.
2. Sharathkumar A, Hirschl R, Pipe S, et al. Primary thromboprophylaxis with heparins for arteriovenous fistula failure in pediatric patients. J Vasc Access 2007;8:235-244.
3. Martinez-Urrutia MJ, Pereira PL, Ramirez LA, et al. Renal transplant in children with previous inferior vena cava thrombosis. Pediatr Transplant 2007; 1:419-421.
4. Casserly LF, Dember LM. Thrombosis in end-stage renal disease. Semin Dial 2003;16:245-256.
5. Monreal M, Falga C, Valle R, et al. Venous thromboembolism in patients with renal insufficiency: Findings from the RIETE registry. Am J Med 2006;119:1073-1079.
6. Brophy DF, Sica DA. Use of enoxaparin in patients with chronic kidney disease: Safety considerations. Drug Safety 2007;30:991-994.
7. Dix D, Andrew M, Marzinotto V, et al. The use of low molecular weight heparin in pediatric patients: A prospective cohort study. J Pediatr 2000;136:439-445.
8. Monagle P, Chan A, Massicotte P, et al. Antithrombotic therapy in children: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:645S-687S.
9. Hirsh J, Raschke R, Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:188S-203S.
10. Lim W, Cook DJ, Crowther MA, Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: A meta-analysis of randomized trials. J Am Soc Nephrol 2004;15:3192-3206.
11. Crowther M, Lim W, Crowther M, et al. Low molecular weight heparin and bleeding in patients with chronic renal failure. Curr Opin Pulm Med 2007;13:409-413.
12. Dentali F, Riva N, Gianni M, Malato A, Bozzato S, Bernasconi M, et al. Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events. Thromb Res 2008; [Epub ahead of print].
13. Becker RC, Spencer FA, Gibson M, et al. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes. Am Heart J 2002;143:753-759.
14. Rabbat CG, Cook DJ, Crowther MA, et al. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency. J Crit Care 2005;20:357-363.
15. Revel-Vilk S, Chan A, Bauman M, et al. Prothrombotic condilions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost 2003;1:915-921.
16. Revel-Vilk S, Kenet G. Thrombophilia in children with venous thromboembolic disease. Thromb Res 2006;118:59-65.
17. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998;133:770-776.
18. Hakim R, Himmelfarb J. Hemodialysis access failure: A call to action. Kidney Int 1998;54:1029-1040.
19. Ruud E, Holmstrom H, De Lange C, et al. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies - A randomized, controlled study. Acta Paediatr 2006;95:1053-1059.
20. Broyer M, Gagnadoux MF, Sierro A, et al. Preventive treatment of vascular thrombosis after kidney transplantation in children with low molecular weight heparin. Transplant Proc 1991;23:1384-1385.